CNS PART 1 Flashcards
NSAIDS for migraines
OTC, Rapid onset, useful in early migraines
-Marked lack of potency for most migraine headaches
-Must be taken early in the migraine attack; delayed administration of these drugs will be ineffective.
Acetaminophen
blocks the synthesis of prostaglandins in the brain
- Has analgesic effect for some migraine headaches if used early in the attack.
- Food does not inhibit oral absorption
- No “cross-sensitivity” with aspirin or the NSAIDs
Hepatotoxicity; especially in patients with pre-existing liver disease. Contraindicated in patients with severe liver dysfunction (i.e., cirrhosis)
- Precautions in patients with renal disease; does have some nephrotoxicity
- Must be taken early in the attack to be effective at all
-NSAIDS are more potent
Aspirin-Caffeine-Butalbital (Fiorinal)
-Very rapid onset of action; 15-30 minutes
-three drugs provides greater potency for migraine relief than the aspirin, NSAIDs, or acetaminophen do alone
-schedule III drug
-Contraindicated in pregnancy; barbiturates are teratogenic
-Precaution in pts with resp diseases
-Risk for addiction, causes hangover effect, contains ASA
Serotonin Agonists;
ergotamine (Ergomar)
long track record of success
-Rapid onset
-sup, sublingual, supp, inhaled
-Can be effective for mild, moderate, and some severe migraine headaches
-Can cause physical dependence- rebound headache
-Most effective if used early
- May cause peripheral vasospasm
- Contraindicated in patients with peripheral vascular disease, coronary occlusive disease, hypertension, or severe renal or hepatic disease
- no for pregos; they cause uterine contractions
- Contraindicated with several drugs;antifungals (such as itraconazole), erythromycin-type antibiotics and HIV protease inhibitors
- Precaution required in children
Serotonin Agonists;DIHYDROERGOTAMINE
-IV, IM ,spray for nausea
-rapid onset
-No risk of physical dependence or abuse
- Causes less nausea and peripheral vasospasm than ergotamine
- May be effective in some patients who do not respond to triptans
-Same contraindications as ergotamine
- Effectiveness decreases the later in the attack the drug is administered
- Not available orally
- Can cause -numbness of the fingers and toes, muscle aches, tachycardia or bradycardia, increase or decrease in blood pressure
Serotonin Agonists; SUMATRIPTAN and the other “Triptans”
- Most effective of all the anti-migraine medications
- Cerebral vasoconstriction is the predominant effect; less peripheral vasoconstriction
- Less nausea
- Still effective if administered late in the attack
- Minimal CNS sedation;
Can be used (with precaution) in pregnancy
Use limited per 24 hrs - Commonly causes tightness in the chest, jaw, and neck; also causes a warm, tingling sensation
- Contraindicated in coronary artery disease, ischemic heart disease, or angina
-May cause dizziness, drowsiness and fatigue
Adjunctive Drugs for the Abortive Treatment of Migraine
Antimedics- metoclopramide (Reglan), prochlorperazine (Compazine), promethazine (Phenergan)
sedatives- butalbital (as in Fiorinal)
narcotics - meperidine (Demerol),codeine (various combinations), butorphanol (Stadol)
Prophylactic Drugs Used for Migraine
Tricyclic Antidepressants
- amitriptyline (Elavil)
Beta Blockers
- propranolol (Inderal)
- atenolol (Tenormin)
Anticonvulsants
- divalproex/valproate (Depakote)
- topiramate (Topamax)
SSRI’s
- fluoxetine (Prozac)
- sertraline (Zoloft)
Monoamine Oxidase Inhibitors
- phenelzine (Nardil)
Calcium Channel Blockers
- nimodipine (Nimotop)
- verapamil (Calan
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists- new migraine med
Additional option for prophylaxis for those currently not controlled on more traditional prophylactic medications. (Aimovig, Ajovy, Emgality, Vyepti)
-Convenient dosing depending on the drug
-Ubrelvy offers another option for abortive therapy
Expensive
- Antibody development (humanized monoclonal antibody)
-Injection site reactions (for those that are not oral)
new Serotonin Agonists-lasmiditan (Reyvow)
Acute TREATMENT med-PO
- Can only take one dose (suppose migraine doesn’t go away?)
-Warnings for driving impairment, CNS depression, Serotonin syndrome, medication overuse headache.
PARKINSONS MEDS
Dopamine Agonists (including inhaled versions), Anticholinergics, Monoamine Oxidase B Inhibitors, COMT Inhibitors, and adenosine receptor antagonists.
DOPAMINE AGONIST DRUGS
For Parkinson’s Disease
amantadine (Symmetrel) (Gocovri) (Osmolex ER)
bromocriptine (Parlodel)
levodopa-carbidopa (Sinemet)
pramipexole (Mirapex)
ropinirole (Requip)
-They mimic actions of dopamine; replace in the brain what the brain is lacking which comes close to a specific correction of the basic pathophysiology.
-useful as monotherapy
-Most require BID to QID dosing
Most require frequent titration of doses; exact dose difficult to establish and it constantly changes
- Most are relatively expensive
- Commonly produce hallucinations
DOPAMINE AGONIST DRUGS
LEVODOPA-CARBIDOPA, LEVODOPA
Levodopa is metabolized into dopamine; carbidopa blocks an enzyme responsible for the peripheral (non-brain) metabolism of levodopa
-. Available in sustained-release
-Only small amounts actually enter the brain because of extensive peripheral metabolism before the drug can get across the blood brain barrier
-over 50% of patients) causes involuntary skeletal muscle movements
May cause orthostatic hypotension
- Can cause a variety of CNS adverse effects; inattention, memory loss, agitation, anxiety, confusion, depression, delirium, inappropriate or excessive sexual behavior, etc.
- Can cause visual problems; blurring, miosis, mydriasis, staring
-May cause excessive nasal discharge
- In general, has a narrow margin of safety.
- Contraindicated in glaucoma and in cases of suspected melanoma; levodopa can stimulate the growth rate of melanoma.
DOPAMINE AGONIST DRUGS-CONT LEVODOPA-CARBIDOPA DISADVANTAGES
less peripheral conversion before entry into the brain.
- Tolerance possible with continuous use
Commonly associated with an “On-Off” Phenomenon; relatively rapid fluctuations (within hours) of poor control of bradykinesia with period of dyskinesia (i.e., periods of muscle rigidity fluctuating with period of involuntary excessive muscle activity
DOPAMINE AGONIST DRUGS-BROMOCRIPTINE
Adjunctive benefit when given concurrently with levodopa-carbidopa; allows a reduction in the dose
- Prevents fluctuations in the patient’s response to levodopa-carbidopa
- May cause drowsiness and headache, and Nausea
- Possible hypotension (orthostatic);in older adults
- Not useful as monotherapy; only effective when used as an adjunct to levodopa - carbidopa
DOPAMINE AGONIST DRUGS-AMANTADINE
Stimulates the release of the body’s natural dopamine from the remaining dopamine-producing neurons; a direct correction of the basic pathophysiology of the disease.
- Dual therapeutic actions; useful as a dopamine agonist in Parkinson’s Disease and, by a different pharmacodynamic mechanism, as an anti-viral agent in influenza.
- No specific contraindications.
- Useful as initial monotherapy; can reduce bradykinesia effectively by itself in many early cases of the disease.
-Has anticholinergic adverse effects, lack potency,
- May cause dizziness, insomnia, ataxia, confusion
- Has a beneficial psychotomimetic effect; improves mood and sense of well-being in Parkinson’s patients
- Minimal adverse effects-Not metabolized
Anticholinergic Drugs: benztropine (Cogentin)
trihexyphenidyl (Artane)
decrease acetylcholine, to balance out the production of dopamine and acetylcholine.
Most useful for the treatment of Parkinsonian tremor; no effect on bradykinesia
- Has anticholinergic effect of producing dry mouth
- Inexpensive
- Useful as adjuncts to the dopamine agonist drugs
- Can be used as initial monotherapy
- Not effective for the bradykinesia or muscle rigidity of Parkinson’s Disease
- Use of these drugs is usually limited to early Parkinsonism; lack potency for severe, advanced cases.
- Contraindicated in glaucoma.
MAO-B Inhibitors-IRREVERSIBLY BOUND
rasagiline (Azilect)
selegiline (Eldepryl) (Deprenyl) (Zelapar)
-May delay the progression of Parkinson’s Disease
-Useful as an adjunct to the dopamine agonist drug
-Not effective as monotherapy
-Cause nausea
- May cause nervousness and anxiety; these are effects of the amphetamine metabolites
- May rarely cause abdominal pain, dry mouth, insomnia, hallucinations, dyskinesias, mood swings.